BCIQ Profiles

Company Profile Report
1221 COVID autoantibodies
BioCentury & Getty Images

Targets & Mechanisms

Tissue-targeting autoantibodies as a driver of long COVID

Dec 22, 2020 | 12:48 AM GMT

One implication of the recent Yale study linking autoantibody production to the development of long COVID is that treatment with therapies directed at B cells or antibody clearance might prove useful in preventing the condition.

But caution would need to be taken to avoid impairing antibody-mediated antiviral responses

Read the full 704 word article

How to gain access

Continue reading with a
two-week free trial.